HEADER ANTIBIOTIC 19-DEC-00 1HH3 TITLE DECAPLANIN FIRST P21-FORM COMPND MOL_ID: 1; COMPND 2 MOLECULE: DECAPLANIN; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: M86-1410 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: UNCULTURED ACTINOMYCETE; SOURCE 3 ORGANISM_TAXID: 100235; SOURCE 4 STRAIN: DSM 4763; SOURCE 5 OTHER_DETAILS: CULTURE Y-86, 36910 KEYWDS ANTIBIOTIC, GLYCOPEPTIDE EXPDTA X-RAY DIFFRACTION AUTHOR C.LEHMANN,L.VERTESSY,G.M.SHELDRICK,Z.DAUTER,M.DAUTER REVDAT 7 29-JUL-20 1HH3 1 COMPND REMARK HETNAM LINK REVDAT 7 2 1 SITE ATOM REVDAT 6 24-APR-19 1HH3 1 SEQRES LINK REVDAT 5 01-MAY-13 1HH3 1 HETSYN REVDAT 4 11-JUL-12 1HH3 1 REMARK HET HETNAM SITE REVDAT 4 2 1 HETATM ANISOU CONECT MASTER REVDAT 3 13-JUL-11 1HH3 1 VERSN REVDAT 2 24-FEB-09 1HH3 1 VERSN REVDAT 1 11-JUL-05 1HH3 0 JRNL AUTH C.LEHMANN,J.E.DEBRECZENI,G.BUNKOCZI,M.DAUTER,Z.DAUTER, JRNL AUTH 2 L.VERTESY,G.M.SHELDRICK JRNL TITL STRUCTURES OF FOUR CRYSTAL FORMS OF DECAPLANIN JRNL REF HELV.CHIM.ACTA V. 86 1478 2003 JRNL REFN ISSN 0018-019X JRNL DOI 10.1002/HLCA.200390131 REMARK 2 REMARK 2 RESOLUTION. 1.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.50 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : SHELLS REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.116 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.115 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.148 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 4.830 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1535 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 31754 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.106 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.105 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.138 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 4.810 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 1335 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 27724 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 311 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 142 REMARK 3 SOLVENT ATOMS : 162 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 150.90 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 352.20 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 3 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 5659 REMARK 3 NUMBER OF RESTRAINTS : 7613 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.017 REMARK 3 ANGLE DISTANCES (A) : 0.029 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.014 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.091 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.099 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.059 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.005 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.028 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.119 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: MOEWS & KRETSINGER, J.MOL.BIOL.91(1973)201-228 REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1HH3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 19-DEC-00. REMARK 100 THE DEPOSITION ID IS D_1290005696. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-OCT-99 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X9B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : CHESS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32325 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.000 REMARK 200 RESOLUTION RANGE LOW (A) : 30.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : 10.20 REMARK 200 R MERGE (I) : 0.04800 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.2200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.10 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.2 REMARK 200 DATA REDUNDANCY IN SHELL : 2.50 REMARK 200 R MERGE FOR SHELL (I) : 0.16600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.450 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: DIRECT METHODS REMARK 200 SOFTWARE USED: SHELXD REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.37 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 39% LI2SO4, 0.2M TRIS 8.5, 20% REMARK 280 GLYCEROL, PH 8.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 19.29900 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D, G, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 DECAPLANIN IS A TRICYCLIC GLYCOPEPTIDE. REMARK 400 HERE, DECAPLSNIN IS REPRESENTED BY GROUPING TOGETHER THE REMARK 400 SEQUENCE (SEQRES) AND THE THREE LIGANDS (HET) BGC, ERE AND RAM. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: DECAPLANIN REMARK 400 CHAIN: A, B, C, D REMARK 400 COMPONENT_1: PEPTIDE LIKE SEQUENCE RESIDUES 1 TO 7 REMARK 400 COMPONENT_2: SUGAR RESIDUES 8, 9 AND 10 REMARK 400 DESCRIPTION: DECAPLANIN IS A TRICYCLIC GLYCOPEPTIDE. REMARK 400 THE SCAFFOLD IS A HEPTAPEPTIDE WITH THE REMARK 400 CONFIGURATION D-D-L-D-D-L-L, GLYCOSYLATED REMARK 400 REMARK 400 THE DECAPLANIN IS GLYCOPEPTIDE, A MEMBER OF ANTIBIOTIC CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: DECAPLANIN REMARK 400 CHAIN: A, B, C, D, E, F, G, H REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 COMPONENT_2: RESIDUE BGC REMARK 400 COMPONENT_3: RESIDUE ERE REMARK 400 COMPONENT_4: RESIDUE RAM REMARK 400 DESCRIPTION: DECAPLANIN IS A TRICYCLIC GLYCOPEPTIDE. THE SCAFFOLD REMARK 400 IS A HEPTAPEPTIDE WITH THE CONFIGURATION D-D-L-D-D-L- REMARK 400 L, GLYCOSYLATED REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MLU A 1 N CN CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH C 2009 O HOH C 2010 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2021 DISTANCE = 6.83 ANGSTROMS REMARK 525 HOH B2019 DISTANCE = 6.35 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1HHA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF DECAPLANIN - SPACE GROUP P6122 REMARK 900 RELATED ID: 1HHC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF DECAPLANIN - SPACE GROUP P21, SECOND FORM REMARK 900 RELATED ID: 1HHF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF DECAPLANIN - SPACE GROUP P6122, SECOND FORM DBREF 1HH3 A 1 7 NOR NOR00692 NOR00692 1 7 DBREF 1HH3 B 1 7 NOR NOR00692 NOR00692 1 7 DBREF 1HH3 C 1 7 NOR NOR00692 NOR00692 1 7 DBREF 1HH3 D 1 7 NOR NOR00692 NOR00692 1 7 SEQRES 1 A 7 MLU OMZ ASN GHP GHP OMX 3FG SEQRES 1 B 7 MLU OMZ ASN GHP GHP OMX 3FG SEQRES 1 C 7 MLU OMZ ASN GHP GHP OMX 3FG SEQRES 1 D 7 MLU OMZ ASN GHP GHP OMX 3FG MODRES 1HH3 OMX A 6 TYR (BETAR)-BETA-HYDROXY-L-TYROSINE MODRES 1HH3 OMX B 6 TYR (BETAR)-BETA-HYDROXY-L-TYROSINE MODRES 1HH3 OMX C 6 TYR (BETAR)-BETA-HYDROXY-L-TYROSINE MODRES 1HH3 OMX D 6 TYR (BETAR)-BETA-HYDROXY-L-TYROSINE HET MLU A 1 8 HET OMZ A 2 14 HET GHP A 4 11 HET GHP A 5 11 HET OMX A 6 13 HET 3FG A 7 13 HET MLU B 1 9 HET OMZ B 2 14 HET GHP B 4 11 HET GHP B 5 11 HET OMX B 6 13 HET 3FG B 7 13 HET MLU C 1 11 HET OMZ C 2 14 HET GHP C 4 11 HET GHP C 5 11 HET OMX C 6 13 HET 3FG C 7 13 HET MLU D 1 9 HET OMZ D 2 14 HET GHP D 4 11 HET GHP D 5 11 HET OMX D 6 13 HET 3FG D 7 13 HET BGC E 1 11 HET RAM E 2 10 HET BGC F 1 13 HET RAM F 2 10 HET BGC G 1 11 HET RAM G 2 10 HET BGC H 1 11 HET RAM H 2 10 HET ERE A 8 10 HET ERE B 8 10 HET GOL B1001 6 HET GOL B1002 6 HET ERE C 8 10 HET ERE D 8 10 HET GOL D1003 6 HETNAM MLU N-METHYL-D-LEUCINE HETNAM OMZ (BETAR)-3-CHLORO-BETA-HYDROXY-D-TYROSINE HETNAM GHP (2R)-AMINO(4-HYDROXYPHENYL)ETHANOIC ACID HETNAM OMX (BETAR)-BETA-HYDROXY-L-TYROSINE HETNAM 3FG (2S)-AMINO(3,5-DIHYDROXYPHENYL)ETHANOIC ACID HETNAM BGC BETA-D-GLUCOPYRANOSE HETNAM RAM ALPHA-L-RHAMNOPYRANOSE HETNAM ERE 4-EPI-VANCOSAMINE HETNAM GOL GLYCEROL HETSYN ERE 4-EPI-VANCOSAMINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 MLU 4(C7 H15 N O2) FORMUL 1 OMZ 4(C9 H10 CL N O4) FORMUL 1 GHP 8(C8 H9 N O3) FORMUL 1 OMX 4(C9 H11 N O4) FORMUL 1 3FG 4(C8 H9 N O4) FORMUL 5 BGC 4(C6 H12 O6) FORMUL 5 RAM 4(C6 H12 O5) FORMUL 9 ERE 4(C7 H15 N O3) FORMUL 11 GOL 3(C3 H8 O3) FORMUL 16 HOH *162(H2 O) LINK C AMLU A 1 N OMZ A 2 1555 1555 1.35 LINK C BMLU A 1 N OMZ A 2 1555 1555 1.36 LINK C OMZ A 2 N ASN A 3 1555 1555 1.32 LINK OH OMZ A 2 C5 GHP A 4 1555 1555 1.39 LINK C ASN A 3 N GHP A 4 1555 1555 1.34 LINK C GHP A 4 N GHP A 5 1555 1555 1.34 LINK C3 GHP A 4 OH OMX A 6 1555 1555 1.38 LINK O4 GHP A 4 C1 BGC E 1 1555 1555 1.40 LINK C GHP A 5 N OMX A 6 1555 1555 1.35 LINK C3 GHP A 5 CG1 3FG A 7 1555 1555 1.51 LINK C OMX A 6 N 3FG A 7 1555 1555 1.33 LINK OC OMX A 6 C1 ERE A 8 1555 1555 1.40 LINK C MLU B 1 N OMZ B 2 1555 1555 1.34 LINK C OMZ B 2 N ASN B 3 1555 1555 1.34 LINK OH OMZ B 2 C5 GHP B 4 1555 1555 1.40 LINK C ASN B 3 N GHP B 4 1555 1555 1.33 LINK C GHP B 4 N GHP B 5 1555 1555 1.35 LINK C3 GHP B 4 OH OMX B 6 1555 1555 1.39 LINK O4 GHP B 4 C1 BGC F 1 1555 1555 1.41 LINK C GHP B 5 N OMX B 6 1555 1555 1.34 LINK C3 GHP B 5 CG1 3FG B 7 1555 1555 1.50 LINK C OMX B 6 N 3FG B 7 1555 1555 1.34 LINK OC OMX B 6 C1 ERE B 8 1555 1555 1.39 LINK C MLU C 1 N OMZ C 2 1555 1555 1.34 LINK C OMZ C 2 N ASN C 3 1555 1555 1.34 LINK OH OMZ C 2 C5 GHP C 4 1555 1555 1.40 LINK C ASN C 3 N GHP C 4 1555 1555 1.34 LINK C GHP C 4 N GHP C 5 1555 1555 1.35 LINK C3 GHP C 4 OH OMX C 6 1555 1555 1.39 LINK O4 GHP C 4 C1 BGC G 1 1555 1555 1.43 LINK C GHP C 5 N OMX C 6 1555 1555 1.35 LINK C3 GHP C 5 CG1 3FG C 7 1555 1555 1.51 LINK C OMX C 6 N 3FG C 7 1555 1555 1.33 LINK OC OMX C 6 C1 ERE C 8 1555 1555 1.40 LINK C MLU D 1 N OMZ D 2 1555 1555 1.34 LINK C OMZ D 2 N ASN D 3 1555 1555 1.30 LINK OH OMZ D 2 C5 GHP D 4 1555 1555 1.39 LINK C ASN D 3 N GHP D 4 1555 1555 1.32 LINK C GHP D 4 N GHP D 5 1555 1555 1.35 LINK C3 GHP D 4 OH OMX D 6 1555 1555 1.38 LINK O4 GHP D 4 C1 BGC H 1 1555 1555 1.43 LINK C GHP D 5 N OMX D 6 1555 1555 1.33 LINK C3 GHP D 5 CG1 3FG D 7 1555 1555 1.50 LINK C OMX D 6 N 3FG D 7 1555 1555 1.33 LINK OC OMX D 6 C1 ERE D 8 1555 1555 1.40 LINK O2 BGC E 1 C1 RAM E 2 1555 1555 1.40 LINK O2 BGC F 1 C1 RAM F 2 1555 1555 1.44 LINK O2 BGC G 1 C1 RAM G 2 1555 1555 1.44 LINK O2 BGC H 1 C1 RAM H 2 1555 1555 1.45 CISPEP 1 GHP A 5 OMX A 6 0 13.03 CISPEP 2 GHP B 5 OMX B 6 0 9.71 CISPEP 3 GHP C 5 OMX C 6 0 3.72 CISPEP 4 GHP D 5 OMX D 6 0 4.47 CRYST1 25.604 38.598 31.713 90.00 105.88 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.039056 0.000000 0.011111 0.00000 SCALE2 0.000000 0.025908 0.000000 0.00000 SCALE3 0.000000 0.000000 0.032784 0.00000 MTRIX1 1 -0.912980 -0.042330 -0.405800 21.28236 1 MTRIX2 1 -0.070920 -0.963000 0.260020 8.59140 1 MTRIX3 1 -0.401790 0.266170 0.876200 3.72184 1 MTRIX1 2 -0.943570 -0.329310 -0.035070 33.79558 1 MTRIX2 2 -0.330350 0.928500 0.169600 1.72432 1 MTRIX3 2 -0.023290 0.171610 -0.984890 -6.57555 1 MTRIX1 3 0.899700 0.341580 0.271790 10.61809 1 MTRIX2 3 0.173270 -0.850930 0.495880 3.43680 1 MTRIX3 3 0.400650 -0.399050 -0.824770 -9.36413 1 HETATM 1 CA AMLU A 1 18.690 12.603 1.259 0.50 12.54 C ANISOU 1 CA AMLU A 1 1475 1204 2087 -589 -552 348 C HETATM 2 CA BMLU A 1 18.669 11.696 0.923 0.50 14.18 C ANISOU 2 CA BMLU A 1 1326 2131 1930 -925 -629 557 C HETATM 3 C AMLU A 1 17.262 12.937 0.746 0.50 10.99 C ANISOU 3 C AMLU A 1 1408 1015 1753 -533 -425 264 C HETATM 4 C BMLU A 1 17.257 12.305 0.607 0.50 12.63 C ANISOU 4 C BMLU A 1 1349 1598 1851 -812 -432 397 C HETATM 5 O AMLU A 1 17.090 13.572 -0.261 0.50 10.72 O ANISOU 5 O AMLU A 1 1428 1216 1428 -80 -78 61 O HETATM 6 O BMLU A 1 16.928 12.669 -0.510 0.50 13.66 O ANISOU 6 O BMLU A 1 1539 2012 1640 -228 -433 37 O HETATM 7 CB AMLU A 1 19.394 13.914 1.154 0.50 16.70 C ANISOU 7 CB AMLU A 1 1295 1245 3805 -491 -1081 971 C HETATM 8 CB BMLU A 1 19.741 12.422 0.130 0.50 13.52 C ANISOU 8 CB BMLU A 1 1464 906 2768 -282 98 341 C HETATM 9 N OMZ A 2 16.328 12.433 1.585 1.00 12.48 N ANISOU 9 N OMZ A 2 1557 1346 1838 -928 -446 315 N HETATM 10 CA OMZ A 2 15.029 13.050 1.436 1.00 10.94 C ANISOU 10 CA OMZ A 2 1726 952 1479 -808 -20 97 C HETATM 11 C OMZ A 2 13.976 12.163 0.762 1.00 7.26 C ANISOU 11 C OMZ A 2 1205 539 1014 -280 -1 94 C HETATM 12 O OMZ A 2 12.916 12.670 0.468 1.00 7.96 O ANISOU 12 O OMZ A 2 1398 615 1012 -21 134 1 O HETATM 13 CB OMZ A 2 14.459 13.640 2.766 1.00 12.71 C ANISOU 13 CB OMZ A 2 2577 1007 1244 -1013 -145 -120 C HETATM 14 OC OMZ A 2 15.467 14.383 3.425 1.00 19.33 O ANISOU 14 OC OMZ A 2 3788 1786 1770 -2093 -325 -96 O HETATM 15 CG OMZ A 2 13.954 12.563 3.706 1.00 9.75 C ANISOU 15 CG OMZ A 2 1899 650 1157 -618 -195 -133 C HETATM 16 CD1 OMZ A 2 12.598 12.277 3.733 1.00 8.29 C ANISOU 16 CD1 OMZ A 2 1663 387 1100 -51 -203 -58 C HETATM 17 CD2 OMZ A 2 14.808 11.784 4.475 1.00 10.20 C ANISOU 17 CD2 OMZ A 2 1447 1238 1190 -648 -310 -128 C HETATM 18 CE1 OMZ A 2 12.104 11.204 4.464 1.00 6.97 C ANISOU 18 CE1 OMZ A 2 1158 510 979 -36 -145 -81 C HETATM 19 CL OMZ A 2 10.449 10.824 4.485 1.00 10.27 CL ANISOU 19 CL OMZ A 2 1553 948 1402 78 -212 -28 CL HETATM 20 CE2 OMZ A 2 14.318 10.736 5.227 1.00 8.19 C ANISOU 20 CE2 OMZ A 2 1215 798 1099 -88 -303 -162 C HETATM 21 CZ OMZ A 2 12.988 10.426 5.187 1.00 6.82 C ANISOU 21 CZ OMZ A 2 1224 547 819 -101 -126 -57 C HETATM 22 OH OMZ A 2 12.529 9.290 5.870 1.00 7.06 O ANISOU 22 OH OMZ A 2 1447 515 722 -1 -101 -106 O